-Big holders% did ramp up....... (Are they really ****88%?)
-low short int%
The rundown weeks ago, was due to lower earnings.... but I see there could be a shift in revenues, because of 2 new supplying agreements for 2 phases 3.
I'm in today for improving qrt.
Apart the above, I see this week a European API supplyer has been acquired by a bigpharma (will post as soon I found it again!!!)..
This could happen as well to CBM if you look at its ridicule $MCap.
BASF offers 12.50 to buy Pronova.....
can't paste link